Literature DB >> 21345952

N-terminal hemagglutinin tag renders lysine-deficient APOBEC3G resistant to HIV-1 Vif-induced degradation by reduced polyubiquitination.

Yudi Wang1, Qiujia Shao, Xianghui Yu, Wei Kong, James E K Hildreth, Bindong Liu.   

Abstract

APOBEC3G, a potent HIV-1 host restriction factor, is overcome by HIV-1 viral infectivity factor (Vif), which induces its polyubiquitination and proteasomal degradation. Here we show that lysine-deficient APOBEC3G with an N-terminal hemagglutinin (HA) tag fusion (HA-A3G20K/R) was resistant to HIV-1 Vif-induced proteasomal degradation. HA-A3G20K/R molecules were packaged into wild-type HIV-1 particles, and HA-A3G20K/R drastically decreased wild-type HIV-1 reverse transcription products and infectivity. We also showed that the N terminus of A3G was a target of polyubiquitination induced by HIV-1 Vif. Thus, fusion of the HA tag to the N terminus of A3G20K/R reduced its polyubiquitination, the likely mechanism for the resistance of this protein to HIV-1 Vif-induced proteasomal degradation. Finding such ways to induce resistance of A3G to Vif may provide new approaches to anti-HIV/AIDS therapy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21345952      PMCID: PMC3126286          DOI: 10.1128/JVI.01925-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  79 in total

1.  Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex.

Authors:  Xianghui Yu; Yunkai Yu; Bindong Liu; Kun Luo; Wei Kong; Panyong Mao; Xiao-Fang Yu
Journal:  Science       Date:  2003-10-16       Impact factor: 47.728

2.  Identification of 81LGxGxxIxW89 and 171EDRW174 domains from human immunodeficiency virus type 1 Vif that regulate APOBEC3G and APOBEC3F neutralizing activity.

Authors:  Ying Dang; Roderick W Davis; Ian A York; Yong-Hui Zheng
Journal:  J Virol       Date:  2010-03-24       Impact factor: 5.103

3.  Phosphorylation of a novel SOCS-box regulates assembly of the HIV-1 Vif-Cul5 complex that promotes APOBEC3G degradation.

Authors:  Andrew Mehle; Joao Goncalves; Mariana Santa-Marta; Mark McPike; Dana Gabuzda
Journal:  Genes Dev       Date:  2004-12-01       Impact factor: 11.361

4.  Mutational alteration of human immunodeficiency virus type 1 Vif allows for functional interaction with nonhuman primate APOBEC3G.

Authors:  Bärbel Schröfelbauer; Tilo Senger; Gerard Manning; Nathaniel R Landau
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

5.  APOBEC3F and APOBEC3G inhibit HIV-1 DNA integration by different mechanisms.

Authors:  Jean L Mbisa; Wei Bu; Vinay K Pathak
Journal:  J Virol       Date:  2010-03-10       Impact factor: 5.103

6.  Alpha interferon potently enhances the anti-human immunodeficiency virus type 1 activity of APOBEC3G in resting primary CD4 T cells.

Authors:  Keyang Chen; Jialing Huang; Chune Zhang; Sophia Huang; Giuseppe Nunnari; Feng-xiang Wang; Xiangrong Tong; Ling Gao; Kristi Nikisher; Hui Zhang
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

7.  A patch of positively charged amino acids surrounding the human immunodeficiency virus type 1 Vif SLVx4Yx9Y motif influences its interaction with APOBEC3G.

Authors:  Gongying Chen; Zhiwen He; Tao Wang; Rongzhen Xu; Xiao-Fang Yu
Journal:  J Virol       Date:  2009-06-17       Impact factor: 5.103

8.  HSP70 protects BCL2L12 and BCL2L12A from N-terminal ubiquitination-mediated proteasomal degradation.

Authors:  Junwu Yang; Yi Hong; Wenzong Wang; Weibing Wu; Yayun Chi; Hongliang Zong; Xiangfei Kong; Yuanyan Wei; Xiaojing Yun; Chunming Cheng; Kangli Chen; Jianxin Gu
Journal:  FEBS Lett       Date:  2009-04-18       Impact factor: 4.124

9.  APOBEC3G restricts early HIV-1 replication in the cytoplasm of target cells.

Authors:  Jenny L Anderson; Thomas J Hope
Journal:  Virology       Date:  2008-03-04       Impact factor: 3.616

10.  Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti-HIV-1 activity.

Authors:  Gang Peng; Ke Jian Lei; Wenwen Jin; Teresa Greenwell-Wild; Sharon M Wahl
Journal:  J Exp Med       Date:  2006-01-17       Impact factor: 14.307

View more
  18 in total

1.  An E3 Ligase Affects the NLR Receptor Stability and Immunity to Powdery Mildew.

Authors:  Tao Wang; Cheng Chang; Cheng Gu; Sanyuan Tang; Qi Xie; Qian-Hua Shen
Journal:  Plant Physiol       Date:  2016-10-25       Impact factor: 8.340

Review 2.  Prospects for lentiviral vector mediated prostaglandin F synthase gene delivery in monkey eyes in vivo.

Authors:  Eun Suk Lee; Carol A Rasmussen; Mark S Filla; Sarah R Slauson; Aaron W Kolb; Donna M Peters; Paul L Kaufman; B'Ann T Gabelt; Curtis R Brandt
Journal:  Curr Eye Res       Date:  2014-02-21       Impact factor: 2.424

3.  Dispersed sites of HIV Vif-dependent polyubiquitination in the DNA deaminase APOBEC3F.

Authors:  John S Albin; John S Anderson; Jeffrey R Johnson; Elena Harjes; Hiroshi Matsuo; Nevan J Krogan; Reuben S Harris
Journal:  J Mol Biol       Date:  2013-01-11       Impact factor: 5.469

Review 4.  Creating genetic resistance to HIV.

Authors:  John C Burnett; John A Zaia; John J Rossi
Journal:  Curr Opin Immunol       Date:  2012-09-15       Impact factor: 7.486

5.  Bi-allelic LoF NRROS Variants Impairing Active TGF-β1 Delivery Cause a Severe Infantile-Onset Neurodegenerative Condition with Intracranial Calcification.

Authors:  Xiaomin Dong; Natalie B Tan; Katherine B Howell; Sabina Barresi; Jeremy L Freeman; Davide Vecchio; Maria Piccione; Francesca Clementina Radio; Daniel Calame; Shan Zong; Stefanie Eggers; Ingrid E Scheffer; Tiong Y Tan; Nicole J Van Bergen; Marco Tartaglia; John Christodoulou; Susan M White
Journal:  Am J Hum Genet       Date:  2020-03-19       Impact factor: 11.025

6.  Differential Contributions of Ubiquitin-Modified APOBEC3G Lysine Residues to HIV-1 Vif-Induced Degradation.

Authors:  Tiffany Turner; Qiujia Shao; Weiran Wang; Yudi Wang; Chenliang Wang; Ballington Kinlock; Bindong Liu
Journal:  J Mol Biol       Date:  2016-06-10       Impact factor: 5.469

7.  GB virus type C E2 protein inhibits human immunodeficiency virus type 1 assembly through interference with HIV-1 gag plasma membrane targeting.

Authors:  Christine L Timmons; Qiujia Shao; Chenliang Wang; Ling Liu; Huanliang Liu; Xinhong Dong; Bindong Liu
Journal:  J Infect Dis       Date:  2013-01-09       Impact factor: 5.226

Review 8.  Host restriction factors in retroviral infection: promises in virus-host interaction.

Authors:  Yong-Hui Zheng; Kuan-Teh Jeang; Kenzo Tokunaga
Journal:  Retrovirology       Date:  2012-12-20       Impact factor: 4.602

9.  Viral takeover of the host ubiquitin system.

Authors:  Jean K Gustin; Ashlee V Moses; Klaus Früh; Janet L Douglas
Journal:  Front Microbiol       Date:  2011-07-28       Impact factor: 5.640

10.  Multi-scale modeling of HIV infection in vitro and APOBEC3G-based anti-retroviral therapy.

Authors:  Iraj Hosseini; Feilim Mac Gabhann
Journal:  PLoS Comput Biol       Date:  2012-02-09       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.